Ann B. Moser

1.3k total citations · 1 hit paper
7 papers, 1.1k citations indexed

About

Ann B. Moser is a scholar working on Molecular Biology, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, Ann B. Moser has authored 7 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Clinical Biochemistry and 2 papers in Epidemiology. Recurrent topics in Ann B. Moser's work include Peroxisome Proliferator-Activated Receptors (6 papers), Metabolism and Genetic Disorders (5 papers) and Adipose Tissue and Metabolism (2 papers). Ann B. Moser is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (6 papers), Metabolism and Genetic Disorders (5 papers) and Adipose Tissue and Metabolism (2 papers). Ann B. Moser collaborates with scholars based in United States and Italy. Ann B. Moser's co-authors include Paul A. Watkins, Huizhi Lin, Xiaoyu Song, Shiqi Yang, Anna Mae Diehl, Zhiping Li, Jiawen Huang, Kirby D. Smith, Jonathan Arias and Sidney Goldfischer and has published in prestigious journals such as The Journal of Cell Biology, Hepatology and Annals of Neurology.

In The Last Decade

Ann B. Moser

7 papers receiving 1.0k citations

Hit Papers

Probiotics and antibodies... 2003 2026 2010 2018 2003 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann B. Moser United States 7 605 563 324 237 123 7 1.1k
Arijeet K. Gattu United States 11 375 0.6× 367 0.7× 210 0.6× 181 0.8× 36 0.3× 19 911
Leela Goodspeed United States 16 401 0.7× 318 0.6× 287 0.9× 167 0.7× 40 0.3× 24 956
Hongdong Wang China 15 240 0.4× 267 0.5× 209 0.6× 208 0.9× 73 0.6× 27 821
Irma García‐Martinez Spain 14 389 0.6× 421 0.7× 136 0.4× 85 0.4× 30 0.2× 25 906
Arumugam Velayudham United States 11 853 1.4× 500 0.9× 187 0.6× 223 0.9× 14 0.1× 11 1.3k
Masahito Ogura Japan 20 302 0.5× 501 0.9× 269 0.8× 369 1.6× 25 0.2× 44 1.2k
George Alexander India 13 260 0.4× 153 0.3× 119 0.4× 137 0.6× 29 0.2× 19 653
Vincenza Cifarelli United States 19 251 0.4× 412 0.7× 331 1.0× 204 0.9× 64 0.5× 32 1.2k
Nuttaporn Wongsiriroj United States 13 437 0.7× 868 1.5× 337 1.0× 260 1.1× 18 0.1× 15 1.8k

Countries citing papers authored by Ann B. Moser

Since Specialization
Citations

This map shows the geographic impact of Ann B. Moser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann B. Moser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann B. Moser more than expected).

Fields of papers citing papers by Ann B. Moser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann B. Moser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann B. Moser. The network helps show where Ann B. Moser may publish in the future.

Co-authorship network of co-authors of Ann B. Moser

This figure shows the co-authorship network connecting the top 25 collaborators of Ann B. Moser. A scholar is included among the top collaborators of Ann B. Moser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann B. Moser. Ann B. Moser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Li, Zhiping, Shiqi Yang, Huizhi Lin, et al.. (2003). Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology. 37(2). 343–350. 758 indexed citations breakdown →
2.
Ito, Masumi, Benjamin M. Blumberg, David J. Mock, et al.. (2001). Potential Environmental and Host Participants in the Early White Matter Lesion of Adreno-Leukodystrophy: Morphologic Evidence for CD8 Cytotoxic T Cells, Cytolysis of Oligodendrocytes, and CD1-Mediated Lipid Antigen Presentation. Journal of Neuropathology & Experimental Neurology. 60(10). 1004–1019. 89 indexed citations
3.
Wei, Heming, Stephan Kemp, Martina C. McGuinness, Ann B. Moser, & Kirby D. Smith. (2000). Pharmacological induction of peroxisomes in peroxisome biogenesis disorders. Annals of Neurology. 47(3). 286–296. 47 indexed citations
4.
Braiterman, Lelita T., et al.. (1999). Peroxisomal Very Long Chain Fatty Acid β-Oxidation Activity Is Determined by the Level of Adrenodeukodystrophy Protein (ALDP) Expression. Molecular Genetics and Metabolism. 66(2). 91–99. 16 indexed citations
5.
Elias, Ellen Roy, Munir Mobassaleh, Amiya K. Hajra, & Ann B. Moser. (1998). Developmental delay and growth failure caused by a peroxisomal disorder, dihydroxyacetonephosphate acyltransferase (DHAP-AT) deficiency. American Journal of Medical Genetics. 80(3). 223–226. 18 indexed citations
6.
Theda, Christiane, et al.. (1992). Phospholipids in X-linked adrenoleukodystrophy white matter: fatty acid abnormalities before the onset of demyelination. Journal of the Neurological Sciences. 110(1-2). 195–204. 81 indexed citations
7.
Arias, Jonathan, Ann B. Moser, & Sidney Goldfischer. (1985). Ultrastructural and cytochemical demonstration of peroxisomes in cultured fibroblasts from patients with peroxisomal deficiency disorders.. The Journal of Cell Biology. 100(5). 1789–1792. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026